Literature DB >> 27071130

Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.

Katrin Klocke1, Shimon Sakaguchi2, Rikard Holmdahl1, Kajsa Wing3.   

Abstract

Cytotoxic T lymphocyte antigen-4 (CTLA-4) is essential for immunological (self-) tolerance, but due to the early fatality of CTLA-4 KO mice, its specific function in central and peripheral tolerance and in different systemic diseases remains to be determined. Here, we further examined the role of CTLA-4 by abrogating CTLA-4 expression in adult mice and compared the resulting autoimmunity that follows with that produced by congenital CTLA-4 deficiency. We found that conditional deletion of CTLA-4 in adult mice resulted in spontaneous lymphoproliferation, hypergammaglobulinemia, and histologically evident pneumonitis, gastritis, insulitis, and sialadenitis, accompanied by organ-specific autoantibodies. However, in contrast to congenital deficiency, this was not fatal. CTLA-4 deletion induced preferential expansion of CD4(+)Foxp3(+) Treg cells. However, T cells from CTLA-4-deficient inducible KO mice were able to adoptively transfer the diseases into T cell-deficient mice. Notably, cell transfer of thymocytes de novo produced myocarditis, otherwise not observed in donor mice depleted in adulthood. Moreover, CTLA-4 deletion in adult mice had opposing impacts on induced autoimmune models. Thus, although CTLA-4-deficient mice had more severe collagen-induced arthritis (CIA), they were protected against peptide-induced experimental autoimmune encephalomyelitis (EAE); however, onset of protein-induced EAE was only delayed. Collectively, this indicates that CTLA-4 deficiency affects both central and peripheral tolerance and Treg cell-mediated suppression.

Entities:  

Keywords:  CTLA-4; Foxp3; autoimmunity; regulatory T cells; tolerance

Mesh:

Substances:

Year:  2016        PMID: 27071130      PMCID: PMC4855592          DOI: 10.1073/pnas.1603892113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

1.  Nature of the collagen synthesized by a transplanted chondrosarcoma.

Authors:  B D Smith; G R Martin; E J Miller; A Dorfman; R Swarm
Journal:  Arch Biochem Biophys       Date:  1975-01       Impact factor: 4.013

2.  Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.

Authors:  Elizabeth A Tivol; Jack Gorski
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

3.  A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection.

Authors:  Janet E Buhlmann; Sheryl Krevsky Elkin; Arlene H Sharpe
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

4.  B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide.

Authors:  J A Lyons; M San; M P Happ; A H Cross
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

5.  CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.

Authors:  T Kouki; Y Sawai; C A Gardine; M E Fisfalen; M L Alegre; L J DeGroot
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) +49 A>G gene polymorphism in Egyptian cases with rheumatoid arthritis.

Authors:  Rami Elshazli; Ahmad Settin; Afrah Salama
Journal:  Gene       Date:  2014-12-24       Impact factor: 3.688

7.  Low-avidity recognition by CD4+ T cells directed to self-antigens.

Authors:  John A Gebe; Ben A Falk; Kellee A Rock; Sharon A Kochik; Anne K Heninger; Helena Reijonen; William W Kwok; Gerald T Nepom
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

8.  Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus.

Authors:  Marta Barreto; Eugénia Santos; Ricardo Ferreira; Constantin Fesel; Maria Francisca Fontes; Clara Pereira; Berta Martins; Rita Andreia; João Faro Viana; Francisco Crespo; Carlos Vasconcelos; Carlos Ferreira; Astrid Moura Vicente
Journal:  Eur J Hum Genet       Date:  2004-08       Impact factor: 4.246

9.  CTLA-4-Ig regulates tryptophan catabolism in vivo.

Authors:  Ursula Grohmann; Ciriana Orabona; Francesca Fallarino; Carmine Vacca; Filippo Calcinaro; Alberto Falorni; Paola Candeloro; Maria L Belladonna; Roberta Bianchi; Maria C Fioretti; Paolo Puccetti
Journal:  Nat Immunol       Date:  2002-09-30       Impact factor: 25.606

10.  A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination.

Authors:  Lars Svensson; Khairul-Bariah Abdul-Majid; Jan Bauer; Hans Lassmann; Robert A Harris; Rikard Holmdahl
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

View more
  72 in total

1.  Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity.

Authors:  Julio C Valencia; Nkolika Egbukichi; Rebecca A Erwin-Cohen
Journal:  J Interferon Cytokine Res       Date:  2018-12-18       Impact factor: 2.607

Review 2.  Immune checkpoint inhibitors in challenging populations.

Authors:  Douglas B Johnson; Ryan J Sullivan; Alexander M Menzies
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

Review 3.  Adverse events associated with immune checkpoint inhibitor treatment for cancer.

Authors:  Khashayar Esfahani; Nicholas Meti; Wilson H Miller; Marie Hudson
Journal:  CMAJ       Date:  2019-01-14       Impact factor: 8.262

4.  Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States.

Authors:  Spencer C Wei; Roshan Sharma; Nana-Ama A S Anang; Jacob H Levine; Yang Zhao; James J Mancuso; Manu Setty; Padmanee Sharma; Jing Wang; Dana Pe'er; James P Allison
Journal:  Immunity       Date:  2019-03-26       Impact factor: 31.745

Review 5.  Cardiovascular toxicities associated with immune checkpoint inhibitors.

Authors:  Jiun-Ruey Hu; Roberta Florido; Evan J Lipson; Jarushka Naidoo; Reza Ardehali; Carlo G Tocchetti; Alexander R Lyon; Robert F Padera; Douglas B Johnson; Javid Moslehi
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

Review 6.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

7.  CTLA-4 expressed by FOXP3+ regulatory T cells prevents inflammatory tissue attack and not T-cell priming in arthritis.

Authors:  Katrin Klocke; Rikard Holmdahl; Kajsa Wing
Journal:  Immunology       Date:  2017-06-20       Impact factor: 7.397

8.  CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.

Authors:  Ning Wang; Shuang Liang; Jingyi Jin; Liang Fang; Qianli Ma; Xian Wang; Yun Song; Lihua Chen
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

Review 9.  Genetic and epigenetic influences on the loss of tolerance in autoimmunity.

Authors:  Peng Zhang; Qianjin Lu
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

Review 10.  T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Authors:  Eoin F McKinney; Kenneth Gc Smith
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.